Adventitial stem cells in vein grafts display multilineage potential that contributes to neointimal formation

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 8, 2013, Pages 1844-1851

  Chen, Yikuan ^a,b   Wong, Mei Mei ^b   Campagnolo, Paola ^b   Simpson, Russell ^b   Winkler, Bernhard ^b   Margariti, Andriani ^b   Hu, Yanhua ^b   Xu, Qingbo ^b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Adventitial tissue; Atherosclerosis; Cell movement; Smooth muscle cells; Stem cells

Indexed keywords

APOLIPOPROTEIN E; STEM CELL ANTIGEN 1; STROMAL CELL DERIVED FACTOR 1;

ADVENTITIA; ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CELL COMPOSITION; CELL CULTURE; CELL DIFFERENTIATION; CLONOGENIC ASSAY; CONTROLLED STUDY; IMMUNOFLUORESCENCE; IN VITRO STUDY; MOUSE; NEOINTIMA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; STAINING; STEM CELL; VASA VASORUM; VEIN GRAFT;

ADVENTITIAL TISSUE; ATHEROSCLEROSIS; CELL MOVEMENT; SMOOTH MUSCLE CELLS; STEM CELLS;

ADVENTITIA; ANIMALS; ANTIGENS, LY; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; COLLAGEN TYPE IV; DISEASE MODELS, ANIMAL; GRAFT OCCLUSION, VASCULAR; INTEGRINS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; NEOINTIMA; STEM CELLS; TRANSPLANTATION, AUTOLOGOUS; VEINS;

EID: 84881030389     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.113.300902     Document Type: Article

References (44)

1. Lee MS, Park SJ, Kandzari DE, Kirtane AJ, Fearon WF, Brilakis ES, Vermeersch P, Kim YH, Waksman R, Mehilli J, Mauri L, Stone GW. Saphenous vein graft intervention. J Am Coll Cardiol Cardiovascular interventions. 2011;4: 831-843.
2. Ip JH, Fuster V, Badimon L, Badimon J, Taubman MB, Chesebro JH. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol. 1990;15: 1667-1687.
3. Mayr M, Li C, Zou Y, Huemer U, Hu Y, Xu Q. Biomechanical stressinduced apoptosis in vein grafts involves p38 mitogen-activated protein kinases. FASEB J. 2000;14: 261-270.
4. Zou Y, Hu Y, Mayr M, Dietrich H, Wick G, Xu Q. Reduced neointima hyperplasia of vein bypass grafts in intercellular adhesion molecule-1- deficient mice. Circ Res. 2000;86: 434-440.
5. Hu Y, Xu Q. Adventitial biology: differentiation and function. Arterioscler Thromb Vasc Biol. 2011;31: 1523-1529.
6. Wilcox JN, Waksman R, King SB, Scott NA. The role of the adventitia in the arterial response to angioplasty: the effect of intravascular radiation. Int J Radiat Oncol Biol Phys. 1996;36: 789-796.
7. Moreno PR, Purushothaman KR, Sirol M, Levy AP, Fuster V. Neovascularization in human atherosclerosis. Circulation. 2006;113: 2245-2252.
8. Gutterman DD. Adventitia-dependent influences on vascular function. Am J Physiol. 1999;277:H1265-H1272.
9. Scotland RS, Vallance PJ, Ahluwalia A. Endogenous factors involved in regulation of tone of arterial vasa vasorum: implications for conduit vessel physiology. Cardiovasc Res. 2000;46: 403-411.
10. Stenmark KR, Davie N, Frid M, Gerasimovskaya E, Das M. Role of the adventitia in pulmonary vascular remodeling. Physiology (Bethesda). 2006;21: 134-145.
11. van der Loo B, Martin JF. The adventitia, endothelium and atherosclerosis. Int J Microcirc Clin Exp. 1997;17: 280-288.
12. Hu Y, Zhang Z, Torsney E, Afzal AR, Davison F, Metzler B, Xu Q. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest. 2004;113: 1258-1265.
13. Torsney E, Xu Q. Resident vascular progenitor cells. J Mol Cell Cardiol. 2011;50: 304-311.
14. Zengin E, Chalajour F, Gehling UM, Ito WD, Treede H, Lauke H, Weil J, Reichenspurner H, Kilic N, Ergün S. Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development. 2006;133: 1543-1551.
15. Xu Q. Biomechanical-stress-induced signaling and gene expression in the development of arteriosclerosis. Trends Cardiovasc Med. 2000;10: 35-41.
16. Ait-Oufella H, Taleb S, Mallat Z, Tedgui A. Recent advances on the role of cytokines in atherosclerosis. Arterioscler Thromb Vasc Biol. 2011;31: 969-979.
17. Wilcox JN, Okamoto EI, Nakahara KI, Vinten-Johansen J. Perivascular responses after angioplasty which may contribute to postangioplasty restenosis: a role for circulating myofibroblast precursors? Ann N Y Acad Sci. 2001;947:68-90; dicussion 90.
18. Fukuda D, Enomoto S, Nagai R, Sata M. Inhibition of renin-angiotensin system attenuates periadventitial inflammation and reduces atherosclerotic lesion formation. Biomed Pharmacother. 2009;63: 754-761.
19. Michel JB, Thaunat O, Houard X, Meilhac O, Caligiuri G, Nicoletti A. Topological determinants and consequences of adventitial responses to arterial wall injury. Arterioscler Thromb Vasc Biol. 2007;27: 1259-1268.
20. Mitchell RN, Libby P. Vascular remodeling in transplant vasculopathy. Circ Res. 2007;100: 967-978.
21. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR, Crystal RG, Besmer P, Lyden D, Moore MA, Werb Z, Rafii S. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell. 2002;109: 625-637.
22. Aicher A, Zeiher AM, Dimmeler S. Mobilizing endothelial progenitor cells. Hypertension. 2005;45: 321-325.
23. Cho HJ, Kim HS, Lee MM, Kim DH, Yang HJ, Hur J, Hwang KK, Oh S, Choi YJ, Chae IH, Oh BH, Choi YS, Walsh K, Park YB. Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelialization and reduce vascular inflammation after intravascular radiation. Circulation. 2003;108: 2918-2925.
24. Kong D, Melo LG, Gnecchi M, Zhang L, Mostoslavsky G, Liew CC, Pratt RE, Dzau VJ. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation. 2004;110: 2039-2046.
25. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 1999;5: 434-438.
26. Cheng J, Wang Y, Liang A, Jia L, Du J. FSP-1 silencing in bone marrow cells suppresses neointima formation in vein graft. Circ Res. 2012;110: 230-240.
27. Schepers A, Eefting D, Bonta PI, Grimbergen JM, de Vries MR, van Weel V, de Vries CJ, Egashira K, van Bockel JH, Quax PH. Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo. Arterioscler Thromb Vasc Biol. 2006;26: 2063-2069.
28. Li G, Chen SJ, Oparil S, Chen YF, Thompson JA. Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries. Circulation. 2000;101: 1362-1365.
29. De Leon H, Ollerenshaw JD, Griendling KK, Wilcox JN. Adventitial cells do not contribute to neointimal mass after balloon angioplasty of the rat common carotid artery. Circulation. 2001;104: 1591-1593.
30. Hu Y, Mayr M, Metzler B, Erdel M, Davison F, Xu Q. Both donor and recipient origins of smooth muscle cells in vein graft atherosclerotic lesions. Circ Res. 2002;91:e13-e20.
31. Campagnolo P, Wong MM, Xu Q. Progenitor cells in arteriosclerosis: good or bad guys? Antioxid Redox Sign. 2011;15: 1013-1027.
32. Xu Q. Stem cells and transplant arteriosclerosis. Circ Res. 2008;102: 1011-1024.
33. Campbell JH, Campbell GR. The role of smooth muscle cells in atherosclerosis. Curr Opin Lipidol. 1994;5: 323-330.
34. Ross R. The pathogenesis of atherosclerosis-an update. N Engl J Med. 1986;314: 488-500.
35. Tang Z, Wang A, Yuan F, Yan Z, Liu B, Chu JS, Helms JA, Li S. Differentiation of multipotent vascular stem cells contributes to vascular diseases. Nat Commun. 2012;3:875.
36. Owens GK. Molecular control of vascular smooth muscle cell differentiation and phenotypic plasticity. Novartis Found Symp. 2007;283:174-191; discussion 191.
37. Xiao Q, Wang G, Luo Z, Xu Q. The mechanism of stem cell differentiation into smooth muscle cells. Thromb Haemost. 2010;104: 440-448.
38. Madsen CS, Hershey JC, Hautmann MB, White SL, Owens GK. Expression of the smooth muscle myosin heavy chain gene is regulated by a negative-acting GC-rich element located between two positive-acting serum response factor-binding elements. J Biol Chem. 1997;272: 6332-6340.
39. Chen J, Kitchen CM, Streb JW, Miano JM. Myocardin: a component of a molecular switch for smooth muscle differentiation. J Mol Cell Cardiol. 2002;34: 1345-1356.
40. Xiao Q, Luo Z, Pepe AE, Margariti A, Zeng L, Xu Q. Embryonic stem cell differentiation into smooth muscle cells is mediated by Nox4-produced H2O2. Am J Physiol Cell Physiol. 2009;296:C711-C723.
41. Margariti A, Xiao Q, Zampetaki A, Zhang Z, Li H, Martin D, Hu Y, Zeng L, Xu Q. Splicing of HDAC7 modulates the SRF-myocardin complex during stem-cell differentiation towards smooth muscle cells. J Cell Sci. 2009;122: 460-470.
42. Pepe AE, Xiao Q, Zampetaki A, Zhang Z, Kobayashi A, Hu Y, Xu Q. Crucial role of nrf3 in smooth muscle cell differentiation from stem cells. Circ Res. 2010;106: 870-879.
43. Wang G, Xiao Q, Luo Z, Ye S, Xu Q. Functional impact of heterogeneous nuclear ribonucleoprotein A2/B1 in smooth muscle differentiation from stem cells and embryonic arteriogenesis. J Biol Chem. 2012;287: 2896-2906.
44. Xiao Q, Pepe AE, Wang G, Luo Z, Zhang L, Zeng L, Zhang Z, Hu Y, Ye S, Xu Q. Nrf3-Pla2g7 interaction plays an essential role in smooth muscle differentiation from stem cells. Arterioscler Thromb Vasc Biol. 2012;32: 730-744.